Fraxel FTX and Fraxel DUAL: Same Laser or Different Devices?

Fraxel FTX: is it the same as Fraxel DUAL or a different machine?

A clinic mentions Fraxel FTX, friends recall Fraxel DUAL, and online both are simply called “Fraxel.” The distinction matters if you are considering treatment for acne scars, spots or fine lines. Fraxel FTX is a separate Solta Medical model and a later technological version of the dual-wavelength Fraxel DUAL system, not another spelling for the old model. Both use nonablative fractional laser treatment at 1550 and 1927 nm, but their handpieces, cooling and motion-tracking systems differ.

Newer does not automatically mean a better result for every skin type. Ergonomic changes may make the device easier for clinicians to use, and built-in cooling may affect comfort. Effectiveness still depends on diagnosis, the selected wavelength, pulse energy, treatment density, aftercare and skin characteristics. Verify the actual device model rather than relying on “the new Fraxel” as a nickname.

What do FDA documents confirm, and when was FTX introduced?

On 21 August 2024, the US Food and Drug Administration made a substantial-equivalence decision under 510(k) number K242142 for Fraxel FTX Laser System. It is a Class II device in the United States, indicated there for use on medical prescription. That clearance applies to this particular model and its stated indications. It does not prove superiority over every other laser and is not FDA “approval” through the PMA route for higher-risk devices.

The manufacturer publicly announced its commercial launch in April 2025. According to Solta, this version includes a lighter handpiece, direct skin cooling, redesigned tips, updated interface and AccuTRAC optical motion tracking. These are manufacturer descriptions of design, not independent proof that every patient gets smoother skin or heals faster.

US regulatory documentation does not automatically establish authorised indications, registration or availability in Armenia, the EU or elsewhere. The sources reviewed do not establish that Fraxel FTX is available in Yerevan. If a clinic offers it, request documentation identifying the actual device, evidence of its lawful use in your country and the treating professional's credentials. A Fraxel logo alone does not establish that the unit is FTX.

Why are there two wavelengths for different goals?

Both wavelengths heat many microscopic spots in the skin while leaving intervening tissue to contribute to healing: fractional photothermolysis. “Nonablative” means the surface is not deliberately vaporised as a continuous layer; thermal injury still occurs. At 1550 nm, treatment acts deeper and is commonly considered for skin texture and scarring. The 1927 nm wavelength acts predominantly in more superficial layers. The clinician must decide which wavelength or sequence is appropriate for the diagnosis and phototype.

Characteristic	1550 nm	1927 nm
Main depth of action	Deeper, including the dermis	Mainly epidermis and superficial dermis
Examples from the US FTX indication document	Skin resurfacing, dyschromia, melasma, wrinkles around the eyes, acne and surgical scars, and certain skin lesions	Actinic keratosis and pigmented lesions including lentigines and freckles
What cannot be promised	Complete removal of deep scars or sagging	Universal melasma treatment or treatment of every spot without diagnosis
What to check	Scar type, overheating and PIH risk	Nature of each pigmented lesion and possible recurrence

There is an important distinction: having two wavelengths in one device does not mean that every US-listed indication applies to each wavelength. Specifically, the FTX FDA document lists melasma for 1550 nm but does not separately list it for 1927 nm. Research into other uses does not rewrite authorised labelling. Actinic keratosis is a potentially precancerous condition: suspicious areas need dermatological assessment rather than unexamined cosmetic treatment.

FTX versus DUAL: what differences matter to a patient?

Fraxel DUAL is the earlier Solta system with the same main wavelengths. FTX retains the treatment principle but updates the device's construction and interface. A 2026 publication described early experience with FTX: 22 practitioners treated 97 patients. Many survey respondents were positive about comfort and visible results. But treatments were not standardised, there was no randomised direct comparison group, not everyone completed every follow-up survey, and the study was manufacturer-sponsored with some authors affiliated with the company.

This supports a description of early real-world user experience, not, on the published evidence available as of October 2026, a conclusion that FTX gives better clinical outcomes than DUAL or shorter downtime for all phototypes. A well-designed treatment on an older system with a competent clinician can be preferable to selecting the newest model by year alone. Conversely, FTX's new features may help experienced operators, without removing the need for medical assessment.

Comparison	Fraxel DUAL	Fraxel FTX
Wavelengths	1550 and 1927 nm	1550 and 1927 nm
Model identity	Earlier dual-wavelength platform	Separate updated device, FDA 510(k) K242142
Design and control	Earlier handpiece and tracking system	Manufacturer-reported new handpiece, cooling and motion tracking
Proven advantage in clinical results	The name alone establishes none	Insufficient robust head-to-head evidence for a general superiority claim
What matters most	Diagnosis, clinician skill, treatment plan, safety and understandable downtime

Which concerns can realistically improve—and which cannot?

For acne scars, the first task is to classify them: small rounded depressions, narrow deep “ice-pick” scars or scars tethered to underlying tissue. One form of heating cannot treat all of them equally; some patients need combined techniques. Pigmentation must be distinguished as lentigo, melasma, post-inflammatory darkening or a suspicious lesion. Fine lines may show moderate textural changes, but brow droop, tissue-related eye bags or deep folds are separate problems.

If you want to look fresher without an obvious intervention, ask what gentler settings can achieve and whether that means more sessions. Higher energy does not guarantee a more attractive result; it may increase redness, swelling and pigmentation risk. A natural result is not about frozen expressions—this laser does not paralyse muscles—but about subtler skin tone and texture changes and how conspicuous healing will be.

What happens during a treatment?

A clinician takes your history, assesses phototype, past laser reactions, herpes, medicines, scarring and diagnosis, then discusses the area, wavelength, realistic improvement and alternatives. Topical anaesthetic may be used. You may feel brief strong heat and prickling; cooling is designed to reduce discomfort, not ensure painless treatment. Appropriate laser-specific eye protection is required for you and every member of the team.

The number of passes, settings and session length are individual. The FTX publication does not supply a universal course that can be replicated at home. Afterwards redness, warmth, puffiness, dryness and roughness may develop. Skin can look distinctly treated even with a nonablative laser. Ask for unretouched recovery examples from a similar phototype and treatment intensity rather than only flawless final photographs.

How many days will treatment remain visible?

“Minimal downtime” in marketing does not tell you when you will look comfortable in public. One woman may have only redness after gentler treatment, another noticeable swelling and bronze-toned skin followed by flaking. Clinical reviews of nonablative fractional lasers describe several days of erythema (redness) and swelling as common, but stronger settings or individual reactions can extend this period.

When	Possible effects	Everyday planning
Immediately after	Burning sensation, redness, heat and puffiness	Avoid booking close-up photography that evening
First days	Redness, dryness and possibly considerable swelling	Allow for remote work if possible
Following days	Roughness, flaking and temporarily more visible spots	Do not pick flakes; agree with clinician when to use cosmetics
Weeks and months	Gradual assessment of colour and texture	Compare similarly lit images after healing

These are estimates, not a guaranteed day of looking normal. Do not book the next session solely according to a package calendar: the skin must recover and be reviewed. Mention any wedding, sunny holiday or series of work meetings before treatment intensity is decided. Do not try to make up for a short deadline with harsh aftercare.

Risks and reasons to postpone

Solta's safety information for the Fraxel family describes possible burns and blisters, temporary or lasting pigment changes, infection, poor healing, scarring and eye injury when protection is inadequate. The manufacturer also calls for assessment of keloid tendency, skin changes after surgery and isotretinoin treatment. Its warning on systemic steroids is stronger: they should be avoided before and throughout the laser course. If steroids have been prescribed for a medical condition, do not stop them yourself; discuss postponing the laser with your treating clinician and prescriber. Settings need particular caution when post-inflammatory hyperpigmentation is more likely. This is not the full restriction list: the current instructions for the exact model and an examination are essential.

Active herpes or other infection, damaged skin, recent heavy tan, impaired healing, suspicious lesions and certain medications require extra review or postponement. Elective treatment during pregnancy and breastfeeding is generally better discussed and deferred because evidence is limited. Professional consensus from 2017 did not support an automatic mandatory delay after isotretinoin for the general class of nonablative fractional lasers; however, the specific Fraxel manufacturer instructions and individual medical risks still need to be respected. Never stop isotretinoin, systemic steroids or other prescribed medication without the prescriber's guidance. Mention prior threads, injections and lasers in the same area.

Follow written instructions for cleansing, moisturising and UV protection. Do not use scrubs, acids, strong massage or retinoids before healing is confirmed. Rapidly worsening pain or redness, blisters, discharge, fever, unusual crusting or spreading rash call for prompt medical contact. Eye pain or vision changes after laser exposure require emergency care. “Everyone has this” is not a reliable safety assessment.

How to judge promises, photos and session numbers

The manufacturer describes improvements in texture, tone and treatment comfort. Such claims help explain the device's design goals but do not replace independent comparisons. Before-and-after photos must be judged by lighting, makeup, angle, timing and selection of favourable cases. A series of consistently photographed results at a stated follow-up is more informative than a dramatic image under different conditions.

Neither US FDA clearance nor one small FTX user-experience study establishes your required number of sessions or percentage of improvement. Several appointments may be appropriate, but the plan should change according to the response and tolerability. If pigmentation worsens or skin takes unusually long to recover, treatment must not simply continue. Course cost depends on region, treatment area, session count and clinical follow-up. Before deciding, ask for an itemised written estimate for the proposed course and verify documents for the actual Fraxel FTX device; US regulatory clearance confirms neither the price nor the availability of that machine in Armenia.

What to ask before choosing FTX specifically

Ask for the exact device name and evidence of its identity: Fraxel FTX, Fraxel DUAL or something else? Which wavelength is appropriate for your diagnosed problem, does that use fall within applicable local indications, and what evidence supports the proposed benefit? Discuss phototype, prior pigment reactions, acne treatment, herpes, eye protection, visible downtime and the complication plan. Ask why this particular unit is being offered rather than another nonablative laser, different resurfacing technique or nonprocedural care.

A good consultation allows you to decline. Without a clear diagnosis, with too little time before an event, following recent sun exposure or in the face of a “latest technology with no side effects” guarantee, postponing is sensible. Modern equipment may be useful, but an accurate diagnosis, competent medical oversight and informed consent matter most.

Frequently asked questions

Does Fraxel FTX use both wavelengths at once in a single pass?

Having two wavelengths does not mean both must be applied simultaneously to every area. The clinician chooses the wavelengths and sequence according to the indication and the exact device instructions.

Can a pigmented spot be treated if it has changed recently?

A dermatologist must assess it first. Changes in size, colour or border, bleeding or unusual evolution need diagnosis—not cosmetic removal before its nature is understood.

Is FTX suitable for rosacea?

It is not a universal standard treatment for rosacea. With active inflammation, establish the diagnosis and discuss interventions with evidence for your particular symptoms, rather than borrowing indications for pigment spots.

Can I schedule another laser session immediately after Fraxel FTX?

No safe interval can be set without examining your skin and reviewing the settings used. Healing may continue after redness has faded. Before combining FTX with another laser or peel, show the clinician the prior wavelength, settings and treatment date; an unusual reaction calls for postponement until assessment.